Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
27.09
+0.01 (0.04%)
At close: Jul 17, 2026, 4:00 PM EDT
27.63
+0.54 (1.99%)
After-hours: Jul 17, 2026, 6:44 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.39 billion as of July 17, 2026. Its market cap has increased by 155.89% in one year.
Market Cap
2.39B
Enterprise Value
1.74B
1-Year Change
155.89%
Ranking
Category
Stock Price
$27.09
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.39B, an increase of 282.17%. That is a compound annual growth rate of 47.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.39B | -16.84% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.53B |
| Pharvaris | 2.44B |
| Kailera Therapeutics | 2.40B |
| Nurix Therapeutics | 2.40B |
| Vericel | 2.38B |
| Agios Pharmaceuticals | 2.36B |
| Biohaven | 2.32B |
| Nektar Therapeutics | 2.31B |